ArticleThe Journal of clinical investigation2022

Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance.

Jia Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.